hsa_circ_0003222 accelerates stemness and progression of non-small cell lung cancer by sponging miR-527

被引：45

作者：

Li, Changhui ^{[1
]}

Zhang, Jiaqi ^{[2
]}

Yang, Xiaohua ^{[3
]}

Hu, Cheng ^{[4
]}

Chu, Tianqing ^{[1
]}

Zhong, Runbo ^{[1
]}

Shen, Yinchen ^{[1
]}

Hu, Fang ^{[1
]}

Pan, Feng ^{[1
]}

Xu, Jianlin ^{[1
]}

Lu, Jun ^{[1
]}

Zheng, Xiaoxuan ^{[1
]}

Zhang, Hai ^{[1
]}

Nie, Wei ^{[1
]}

Han, Baohui ^{[1
]}

Zhang, Xueyan ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm, Shanghai, Peoples R China

[2] Shanghai Univ Tradit Chinese Med, Shanghai TCM Integrated Inst Vasc Anomalies, Shanghai TCM Integrated Hosp, Shanghai 200082, Peoples R China

[3] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Cent Lab, Shanghai, Peoples R China

[4] Shanghai Univ Tradit Chinese Med, Expt Ctr Sci & Technol, Shanghai 201203, Peoples R China

来源：

CELL DEATH & DISEASE | 2021年 / 12卷 / 09期

关键词：

CIRCULAR RNA; PROLIFERATION; EPIDEMIOLOGY; EXPRESSION; MIGRATION; INVASION; NSCLC;

D O I：

10.1038/s41419-021-04095-8

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The relationship between circular RNA (circRNA) and cancer stem cells (CSCs) is uncertain. We have investigated the combined influence of CSCs, circRNA (hsa_circ_0003222), and immune checkpoint inhibitors in NSCLC progression and therapy resistance. We constructed lung CSCs (LCSCs; PC9 and A549). The effects of hsa_circ_0003222 in vitro were determined by cell counting, colony and sphere formation, and Transwell assays. A tumor xenograft model of metastasis and orthotopic model were built for in vivo analysis. We found that hsa_circ_0003222 was highly expressed in NSCLC tissues and LCSCs. Higher levels of hsa_circ_0003222 were associated with the stage, metastasis, and survival rate of patients with NSCLC. Reduced levels of hsa_circ_0003222 decreased tumor cell proliferation, migration, invasion, stemness-like properties, and chemoresistance. The silencing of hsa_circ_0003222 was found to downregulate PHF21B expression and its downstream, beta-catenin by relieving the sponging effect of miR-527. Moreover, silencing hsa_circ_0003222 alleviated NSCLC resistance to anti-programmed cell death-ligand 1 (PD-L1)-based therapy in vivo. Our data demonstrate the significant role of hsa_circ_0003222 in NSCLC cell stemness-like properties. The manipulation of circRNAs in combination with anti-PD-L1 therapy may alleviate NSCLC stemness and progression.

引用

页数：10

共 40 条

[1] Lung Cancer 2020 Epidemiology, Etiology, and Prevention [J].

Bade, Brett C. ;

Dela Cruz, Charles S. .

CLINICS IN CHEST MEDICINE, 2020, 41 (01) :1-+

[2] Recent Advances in Cancer Stem Cell-Targeted Immunotherapy [J].

Badrinath, Narayanasamy ;

Yoo, So Young .

CANCERS, 2019, 11 (03)

[3] Global Epidemiology of Lung Cancer [J].

Barta, Julie A. ;

Powell, Charles A. ;

Wisnivesky, Juan P. .

ANNALS OF GLOBAL HEALTH, 2019, 85 (01)

[4] PHF21B as a candidate tumor suppressor gene in head and neck squamous cell carcinomas [J].

Bertonha, Fernanda Bernardi ;

Barros Filho, Mateus de Camargo ;

Kuasne, Hellen ;

dos Reis, Patricia Pintor ;

Prando, Erika da Costa ;

Augusto Moyano Munoz, Juan Jose ;

Roffe, Martin ;

Maroso Hajj, Glaucia Noeli ;

Kowalski, Luiz Paulo ;

Rainho, Claudia Aparecida ;

Rogatto, Silvia Regina .

MOLECULAR ONCOLOGY, 2015, 9 (02) :450-462

[5] A novel circular RNA, hsa_circ_0043278, acts as a potential biomarker and promotes non-small cell lung cancer cell proliferation and migration by regulating miR-520f [J].

Cui, Jinggang ;

Li, Wei ;

Liu, Guohua ;

Chen, Xiaojun ;

Gao, Xiaolai ;

Lu, Huiling ;

Lin, Dang .

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) :810-821

[6] Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment [J].

Duma, Narjust ;

Santana-Davila, Rafael ;

Molina, Julian R. .

MAYO CLINIC PROCEEDINGS, 2019, 94 (08) :1623-1640

[7] Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non-Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2 [J].

Geng, Ying ;

Bao, Yongxia ;

Zhang, Wei ;

Deng, Lili ;

Su, Dongju ;

Zheng, Hongyan .

MOLECULAR CANCER RESEARCH, 2020, 18 (05) :748-756

[8] Maintenance Chemotherapy for Advanced Non-Small-Cell Lung Cancer: New Life for an Old Idea [J].

Gerber, David E. ;

Schiller, Joan H. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (08) :1009-1020

[9] Toxicity management with combination chemotherapy and programmed death 1/programmed death ligand 1 inhibitor therapy in advanced lung cancer [J].

Hoffner, Brianna ;

Leighl, Natasha B. ;

Davies, Marianne .

CANCER TREATMENT REVIEWS, 2020, 85

[10] MicroRNA-527 inhibits TGF-β/SMAD induced epithelial-mesenchymal transition via downregulating SULF2 expression in non-small-cell lung cancer [J].

Huo, Wei ;

Zhu, Xiao-Min ;

Pan, Xin-Yan ;

Du, Min ;

Sun, Zhuo ;

Li, Zhi-Min .

MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2019, 16 (05) :4607-4621

← 1 2 3 4 →